UK consults on hospital discharge payment plans:
This article was originally published in Clinica
The UK has launched a consultation on plans to introduce a reimbursement scheme aimed at discouraging unnecessary delays in discharge from hospitals. The initiative, part of the government's drive to improve hospital activity, is based on a system used across Scandinavia, where it is said to have had a "major impact" on reducing discharge delays. The initiative, announced in April 2002, will be open to consultation until September 18 2002. The government has allocated a 6% increase in funding over the next three years - rising by £1bn ($1.53bn) a year by 2006 - to improve services for the care of older people. In March 2002 there were 4,691 patients awaiting discharge, compared to 5,938 a year earlier. Since September 2001, the number of patients awaiting discharge has fallen by 800.
You may also be interested in...
Public Company Edition: Lixte’s small uplisting was the only biopharma initial public offering in the US during Thanksgiving week, but IPOs are ramping up again. Also, LifeSci launched its second SPAC and in follow-on offerings Reata brought in $281m and Intellia grossed $175m.
Orladeyo is the first oral prophylactic approved in the US for hereditary angioedema, with Japan and EU approvals expected to follow. Pricing of $485,000 a year undercuts segment leader.
Results of Study to Assess Statin Residual Risk with Epanova in High Cardiovascular Risk Patients with Hypertriglyceridemia “should prompt reconsideration of [OTC] mixed omega-3 fatty acid products for [atherosclerotic cardiovascular disease] prevention,” say cardiologists in an editorial published with JAMA study.